Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G-R Burmester

Showing results (341-350 of 380) with videos related to

Pageof 38
Sort By:
Arthritis and Rheumatism|October 23, 2001
Strong acceleration of murine lupus by injection of the SmD1(83-119) peptideG Riemekasten, A Kawald, C Weiss, et al.
Annals of the Rheumatic Diseases|September 30, 2005
Prospective 7 year follow up imaging study comparing radiography, ultrasonography, and magnetic resonance imaging in rheumatoid arthritis finger jointsA K Scheel, K-G A Hermann, S Ohrndorf, et al.
Scandinavian Journal of Rheumatology|October 3, 2008
Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synoviumC P Bramlage, C Kaps, U Ungethüm, et al.
Annals of the Rheumatic Diseases|February 2, 2006
Membrane glucocorticoid receptors are down regulated by glucocorticoids in patients with systemic lupus erythematosus and use a caveolin-1-independent expression pathwayC M Spies, D H S Schaumann, T Berki, et al.
Arthritis and Rheumatism|June 3, 2008
Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapyE Keystone, G R Burmester, R Furie, et al.
Annals of the Rheumatic Diseases|July 16, 2002
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatologyF Buttgereit, J A P da Silva, M Boers, et al.
Annals of the Rheumatic Diseases|August 7, 2004
First clinical evaluation of sagittal laser optical tomography for detection of synovitis in arthritic finger jointsA K Scheel, M Backhaus, A D Klose, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritisR Knevel, M Schoels, T W J Huizinga, et al.
Annals of the Rheumatic Diseases|October 14, 2004
Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004D E Furst, F C Breedveld, J R Kalden, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002)D E Furst, F C Breedveld, J R Kalden, et al.
Pageof 38

Showing results (341-350 of 380) with videos related to

Sort By:
Pageof 38
Arthritis and Rheumatism|October 23, 2001
Strong acceleration of murine lupus by injection of the SmD1(83-119) peptideG Riemekasten, A Kawald, C Weiss, et al.
Annals of the Rheumatic Diseases|September 30, 2005
Prospective 7 year follow up imaging study comparing radiography, ultrasonography, and magnetic resonance imaging in rheumatoid arthritis finger jointsA K Scheel, K-G A Hermann, S Ohrndorf, et al.
Scandinavian Journal of Rheumatology|October 3, 2008
Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synoviumC P Bramlage, C Kaps, U Ungethüm, et al.
Annals of the Rheumatic Diseases|February 2, 2006
Membrane glucocorticoid receptors are down regulated by glucocorticoids in patients with systemic lupus erythematosus and use a caveolin-1-independent expression pathwayC M Spies, D H S Schaumann, T Berki, et al.
Arthritis and Rheumatism|June 3, 2008
Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapyE Keystone, G R Burmester, R Furie, et al.
Annals of the Rheumatic Diseases|July 16, 2002
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatologyF Buttgereit, J A P da Silva, M Boers, et al.
Annals of the Rheumatic Diseases|August 7, 2004
First clinical evaluation of sagittal laser optical tomography for detection of synovitis in arthritic finger jointsA K Scheel, M Backhaus, A D Klose, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritisR Knevel, M Schoels, T W J Huizinga, et al.
Annals of the Rheumatic Diseases|October 14, 2004
Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004D E Furst, F C Breedveld, J R Kalden, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002)D E Furst, F C Breedveld, J R Kalden, et al.
Pageof 38